|
|
| Quarterly Results |
|
| Zydus Lifesciences Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Pankaj R Patel | | Home : Cadila | Book Value: 145.1076344 | | BSE Code : 532321 | Market Cap: 99425.98 | | NSE Code : ZYDUSLIFE | P / E : 36.99 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 2225.10 | 2050.00 | 2869.90 | 2437.30 | | Other Income | 106.80 | 534.50 | 82.40 | 251.20 | | Total Income | 2478.10 | 2693.80 | 3038.10 | 2830.50 | | Total Expenditure | 1672.20 | 1509.90 | 1814.70 | 2010.60 | | Operating Profit | 805.90 | 1183.90 | 1223.40 | 819.90 | | Interest | 103.90 | 90.90 | 89.70 | 85.00 | | Gross Profit | 702.00 | 1093.00 | 1133.70 | 734.90 | | Depreciation | 127.70 | 124.90 | 121.20 | 119.90 | | Tax | 118.80 | 171.60 | 236.40 | 129.60 | | Deferred Tax | 5.10 | -8.50 | -4.80 | -5.30 | | Reported Profit After Tax | 450.40 | 805.00 | 780.90 | 490.70 |
|
|
|
|
|